Solasodine Glycosides from the Eggplant in a Topical Cream Psorend<sup>BEC</sup> Are Effective against Psoriasis

Abstract

Background: Psoriasis is a chronic disease that can have significant effects on quality of life. Aim: To test whether the antineoplastic, antipathogenic plant derived secondary metabolites, solasodine glycosides, can treat psoriasis. Case Presentation: We report a case of a 54-year-old French-Vietnamese male who presented with diagnosed erythematous scaly annular recalcitrant psoriasis scattered throughout his body. Method: After failing conventional treatment regimens for over 10 years the patient received a trial with a topical cream formulation Psorend BEC , containing solasodine glycosides, for his psoriasis. Result: Topical applications of Psorend BEC twice daily resulted in complete resolution of cutaneous lesions after 4 weeks of treatment with no recurrence post 1 year after therapy. Conclusion: Topical Psorend BEC therapy rapidly removes recalcitrant psoriasis with no apparent side effects.Psoriasis affects people of all ages, and in all countries. The reported prevalence of psoriasis in adults ranges from 0.5% -11.4% and 0 -1.4% in children, making psoriasis a serious global problem [1]. According to the International

Evaluation of Dermal Irritation and Skin Sensitization by Curaderm

“…Similarly, BEC when added to an anti-psoriasis cream formulation vastly improves its therapeutic effect [33].…”